231 related articles for article (PubMed ID: 15976216)
1. The effect of sildenafil on pulmonary embolism-induced oxidative stress and pulmonary hypertension.
Dias-Junior CA; Souza-Costa DC; Zerbini T; da Rocha JB; Gerlach RF; Tanus-Santos JE
Anesth Analg; 2005 Jul; 101(1):115-20, table of contents. PubMed ID: 15976216
[TBL] [Abstract][Full Text] [Related]
2. Nitrite or sildenafil, but not BAY 41-2272, blunt acute pulmonary embolism-induced increases in circulating matrix metalloproteinase-9 and oxidative stress.
Dias-Junior CA; Cau SB; Oliveira AM; Castro MM; Montenegro MF; Gerlach RF; Tanus-Santos JE
Thromb Res; 2009 Jul; 124(3):349-55. PubMed ID: 19150571
[TBL] [Abstract][Full Text] [Related]
3. Sildenafil improves the beneficial haemodynamic effects of intravenous nitrite infusion during acute pulmonary embolism.
Dias-Junior CA; Montenegro MF; Florencio BC; Tanus-Santos JE
Basic Clin Pharmacol Toxicol; 2008 Oct; 103(4):374-9. PubMed ID: 18834358
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic effects of combined sildenafil and L-arginine during acute pulmonary embolism-induced pulmonary hypertension.
Souza-Silva AR; Dias-Junior CA; Uzuelli JA; Moreno H; Evora PR; Tanus-Santos JE
Eur J Pharmacol; 2005 Nov; 524(1-3):126-31. PubMed ID: 16253237
[TBL] [Abstract][Full Text] [Related]
5. Sildenafil selectively inhibits acute pulmonary embolism-induced pulmonary hypertension.
Dias-Junior CA; Vieira TF; Moreno H; Evora PR; Tanus-Santos JE
Pulm Pharmacol Ther; 2005; 18(3):181-6. PubMed ID: 15707852
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic effects of inducible nitric oxide synthase inhibition combined with sildenafil during acute pulmonary embolism.
Dias-Junior CA; Neto-Neves EM; Montenegro MF; Tanus-Santos JE
Nitric Oxide; 2010 Dec; 23(4):284-8. PubMed ID: 20804854
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic effects of sildenafil interaction with a nitric oxide donor compound in a dog model of acute pulmonary embolism.
Dias-Junior CA; Tanus-Santos JE
Life Sci; 2006 Jun; 79(5):469-74. PubMed ID: 16504213
[TBL] [Abstract][Full Text] [Related]
8. A role for matrix metalloproteinase-9 in the hemodynamic changes following acute pulmonary embolism.
Fortuna GM; Figueiredo-Lopes L; Dias-Junior CA; Gerlach RF; Tanus-Santos JE
Int J Cardiol; 2007 Jan; 114(1):22-7. PubMed ID: 16650492
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of atorvastatin in rat models of acute pulmonary embolism: involvement of matrix metalloproteinase-9.
Souza-Costa DC; Figueiredo-Lopes L; Alves-Filho JC; Semprini MC; Gerlach RF; Cunha FQ; Tanus-Santos JE
Crit Care Med; 2007 Jan; 35(1):239-45. PubMed ID: 17133179
[TBL] [Abstract][Full Text] [Related]
10. Sildenafil improves the beneficial hemodynamic effects exerted by atorvastatin during acute pulmonary thromboembolism.
Neto-Neves EM; Dias-Junior CA; Uzuelli JA; Pereira RP; Spiller F; Czaikoski PG; Tanus-Santos JE
Eur J Pharmacol; 2011 Nov; 670(2-3):554-60. PubMed ID: 21946107
[TBL] [Abstract][Full Text] [Related]
11. Effects of phosphodiesterase 5 inhibitor on pulmonary vascular reactivity in the fetal lamb.
Jaillard S; Larrue B; Deruelle P; Delelis A; Rakza T; Butrous G; Storme L
Ann Thorac Surg; 2006 Mar; 81(3):935-42. PubMed ID: 16488698
[TBL] [Abstract][Full Text] [Related]
12. Oral sildenafil reduces pulmonary hypertension after cardiac surgery.
Trachte AL; Lobato EB; Urdaneta F; Hess PJ; Klodell CT; Martin TD; Staples ED; Beaver TM
Ann Thorac Surg; 2005 Jan; 79(1):194-7; discussion 194-7. PubMed ID: 15620942
[TBL] [Abstract][Full Text] [Related]
13. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
Schäfer S; Ellinghaus P; Janssen W; Kramer F; Lustig K; Milting H; Kast R; Klein M
Cardiovasc Res; 2009 Apr; 82(1):30-9. PubMed ID: 19131365
[TBL] [Abstract][Full Text] [Related]
14. Sildenafil prevents cardiovascular changes after bone marrow fat embolization in sheep.
Krebs J; Ferguson SJ; Nuss K; Leskosek B; Hoerstrup SP; Goss BG; Aebli N
Anesthesiology; 2007 Jul; 107(1):75-81. PubMed ID: 17585218
[TBL] [Abstract][Full Text] [Related]
15. Systemic and splanchnic haemodynamic effects of sildenafil in an in vivo animal model of cirrhosis support for a risk in cirrhotic patients.
Colle I; De Vriese AS; Van Vlierberghe H; Lameire NH; DeVos M
Liver Int; 2004 Feb; 24(1):63-8. PubMed ID: 15102002
[TBL] [Abstract][Full Text] [Related]
16. Effects of sildenafil on pulmonary hypertension and levels of ET-1, eNOS, and cGMP in aorta-banded rats.
Dai ZK; Tan MS; Chai CY; Chou SH; Lin PC; Yeh JL; Jeng AY; Chang CI; Chen IJ; Wu JR
Exp Biol Med (Maywood); 2006 Jun; 231(6):942-7. PubMed ID: 16741028
[TBL] [Abstract][Full Text] [Related]
17. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.
Botha P; Parry G; Dark JH; Macgowan GA
J Heart Lung Transplant; 2009 Jul; 28(7):676-82. PubMed ID: 19560695
[TBL] [Abstract][Full Text] [Related]
18. Effect of oral sildenafil citrate on intraoperative hemodynamics in patients with pulmonary hypertension undergoing valvular heart surgery.
Shim JK; Choi YS; Oh YJ; Kim DH; Hong YW; Kwak YL
J Thorac Cardiovasc Surg; 2006 Dec; 132(6):1420-5. PubMed ID: 17140970
[TBL] [Abstract][Full Text] [Related]
19. Ranolazine, a novel anti-anginal agent, does not alter isosorbide dinitrate- or sildenafil-induced changes in blood pressure in conscious dogs.
Zhao G; Messina E; Xu X; Ochoa M; Serpillon S; Shryock J; Belardinelli L; Hintze TH
Eur J Pharmacol; 2006 Jul; 541(3):171-6. PubMed ID: 16777088
[TBL] [Abstract][Full Text] [Related]
20. Effect of sildenafil on pulmonary artery pressure, systemic pressure, and nitric oxide utilization in patients with left ventricular assist devices.
Klodell CT; Morey TE; Lobato EB; Aranda JM; Staples ED; Schofield RS; Hess PJ; Martin TD; Beaver TM
Ann Thorac Surg; 2007 Jan; 83(1):68-71; discussion 71. PubMed ID: 17184632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
